Evidence map›Paper›PMID 33609000›Full record

ArticleAsia-Pacific journal of clinical oncology2021

Clinical features and prognosis of patients with COVID-19 after lung surgery: A retrospective clinical study.

Jie Bai, Hongling Chu, Shaohua Ma, Qinggang Ge

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asia-Pacific journal of clinical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jie BaiDepartment of Thoracic Surgery, Peking University Third Hospital, Beijing, China.
Hongling ChuResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
Shaohua MaDepartment of Thoracic Surgery, Peking University Third Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-7399-6975
Qinggang GeDepartment of Intensive Care Unit, Peking University Third Hospital, Beijing, China.

Funding

Project of Development Center for Medical Science and Technology, National Health Commission of the PRC; W2017ZWS17
6 · The paper itself

Abstract

aimTo evaluate whether the history of lung surgery in patients was associated with poor prognosis of coronavirus disease 2019 (COVID-19).

methodsClinical data of patients with COVID-19 in a single-center were retrospectively analyzed. Patients with and without lung surgery were matched in 1:4 ratio to compare the differences in clinical characteristics, laboratory results, computed tomography findings, treatment regimens, and prognosis between them.

resultsFour patients had a history of lung surgery. The time from surgery to COVID-19 onset ranged from 3 to 10 days, with a median of 6.75 days. The mortality rate in the surgical group was higher than that in the nonsurgical group (25.0% vs. 6.3%).

conclusionPatients contracting COVID-19 after lung surgery presented a higher death rate; hence, it is necessary to omit lung surgery in patients with active COVID-19 infection.

Indexed as

COVID-19HumansLungPrognosisRetrospective StudiesSARS-CoV-2coronavirus disease 2019immunosuppressionlung cancerlung functionlung surgery

Identifiers

PMID33609000
PMCPMC8013518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.